Glanbia (OTCMKTS:GLAPY) Hits New 12-Month High – Still a Buy?
by Amy Steele · The Cerbat GemGlanbia Plc ADR (OTCMKTS:GLAPY – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $102.21 and last traded at $102.21, with a volume of 153 shares changing hands. The stock had previously closed at $99.00.
Wall Street Analysts Forecast Growth
Several research analysts recently issued reports on GLAPY shares. Kepler Capital Markets cut Glanbia from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 4th. Zacks Research upgraded Glanbia to a “hold” rating in a report on Tuesday, March 3rd. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Glanbia currently has a consensus rating of “Hold”.
Check Out Our Latest Research Report on Glanbia
Glanbia Price Performance
The company has a 50-day moving average of $98.47 and a 200 day moving average of $89.30. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.81 and a current ratio of 1.36.
Glanbia Company Profile
Glanbia plc is a global nutrition company headquartered in Kilkenny, Ireland. The company operates through two principal divisions: Performance Nutrition and Glanbia Nutritionals. Performance Nutrition develops and markets sports and lifestyle nutrition products, including powders, bars and ready-to-drink beverages for athletes and fitness enthusiasts. Glanbia Nutritionals supplies dairy-based ingredients, specialty cheeses, whey proteins, nutrient premixes and functional food solutions to food, beverage and supplement manufacturers worldwide.
Glanbia was formed in 1997 through the merger of Avonmore Food plc and Waterford Foods plc.